Pionyr Immunotherapeutics

About:

Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.

Website: http://www.pionyrtx.com/

Twitter/X: Pionyrimmunotx

Top Investors: Mission BioCapital, New Enterprise Associates, OrbiMed, SV Health Investors, Gilead Sciences

Description:

Pionyr Immunotherapeutics is developing cancer immunotherapies that target the tumor microenvironment to enhance the body’s antitumor immunity. The company is exploiting novel target discovery and antibody generation platform technologies to create the next generation of immuno-oncology therapeutics. The company’s approach, Myeloid Tuning™, is designed to enhance the immune system’s anti-tumor response by altering the cellular infiltrate of the tumor microenvironment with high specificity.